ClinConnect ClinConnect Logo
Search / Trial NCT06615934

Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients

Launched by TEHRAN UNIVERSITY OF MEDICAL SCIENCES · Sep 26, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Physiotherapy Aerobic Exercise Resistance Exercise Liver Transplant Recipients

ClinConnect Summary

This clinical trial is studying the effects of aerobic (like jogging or cycling) and resistance exercises (like lifting weights) on patients who have just received a liver transplant. The goal is to see if these exercises can help improve recovery, boost muscle strength, and support overall health after surgery. Researchers believe that starting a combination of these exercises while patients are still in the hospital could help reduce complications, such as transplant rejection, and enhance the success of the transplant.

To participate in this trial, individuals must be at least 18 years old and undergoing their first liver transplant. They should not have other organ transplants or significant complications that would prevent them from exercising. Participants can expect to take part in a tailored exercise program during their hospital stay, which could lead to better recovery and healthier outcomes in the long run. This study is important because it aims to create a specific exercise plan for liver transplant patients, something that hasn't been done before.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients who undergo elective surgery after the approval of the liver transplant commission.
  • 2. Having an underlying liver disease with metabolic disorder (as determined by the Liver Transplantation Commission)
  • 3. Absence of transplantation of other organs
  • 4. No re-transplantation of the liver
  • 5. Age more than 18 years
  • 6. Ability to participate in initial evaluations
  • 7. Patient's ability to understand questionnaire questions
  • Exclusion Criteria:
  • 1. The patient's lack of satisfaction with continuing cooperation for any reason
  • 2. Re-transplantation up to 3 months after discharge
  • 3. Facing the patient with early allograft dysfunction or primary nonfunction
  • 4. Encountering the criteria of non-implementation of the intervention during 50% of the days of stay in the hospital or more
  • 5. Patients with Postoperative respiratory failure (Extubation \> 48 hours)

About Tehran University Of Medical Sciences

Tehran University of Medical Sciences (TUMS) is a prestigious institution dedicated to advancing healthcare through innovative research and education. As a leading clinical trial sponsor, TUMS is committed to conducting high-quality, ethically sound clinical research that contributes to the understanding and treatment of various medical conditions. With a strong emphasis on collaboration and interdisciplinary approaches, TUMS harnesses the expertise of its diverse faculty and state-of-the-art facilities to facilitate groundbreaking studies that aim to improve patient outcomes and enhance public health. Through its rigorous oversight and adherence to regulatory standards, TUMS ensures the integrity and reliability of its clinical trials, fostering trust and transparency in the research community.

Locations

Tehran, , Iran, Islamic Republic Of

Patients applied

0 patients applied

Trial Officials

Behrouz Attarbashi Moghadam, Ph.D.

Principal Investigator

Department of Physiotherapy,Tehran University of Medical Sciences,Tehran,Iran.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported